Fucoidan/VEGF-based surface modification of decellularized pulmonary heart valve improves the antithrombotic and re-endothelialization potential of bioprostheses.

Marinval, N

Fucoidan/VEGF-based surface modification of decellularized pulmonary heart valve improves the antithrombotic and re-endothelialization potential of bioprostheses. [electronic resource] - Biomaterials 07 2018 - 14-29 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1878-5905

10.1016/j.biomaterials.2018.01.054 doi


Animals
Biocompatible Materials--metabolism
Biomechanical Phenomena
Bioprosthesis--adverse effects
Cell Adhesion--drug effects
Cell Proliferation--drug effects
Cell Survival--drug effects
Coculture Techniques--methods
Fibrinolytic Agents--metabolism
Heart Valves--drug effects
Human Umbilical Vein Endothelial Cells--metabolism
Humans
Polysaccharides--metabolism
Pulmonary Valve--drug effects
Stem Cells--metabolism
Surface Properties
Swine
Tissue Engineering--methods
Tissue Scaffolds--chemistry
Vascular Endothelial Growth Factors--metabolism